Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tolls for B cells.

Simon Fillatreau1, Rudolf A Manz

  • 1Department for Humoral Immunology & Department for Immune Regulation, German Arthritis Research Centre, Berlin, Germany. fillatreau@drfz.de

European Journal of Immunology
|March 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B-cell maturation antigen-Targeted T-cell Engager Therapy Combined with B-cell Depletion for Treatment of Refractory HLA Sensitization.

Kidney international·2026
Same author

Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.

Nature communications·2026
Same author

The discovery of regulatory T cells: a paradigm shift in immunology.

Cellular immunology·2025
Same author

Distinct autoreactive CD19<sup>-</sup> plasma cell subsets accumulate in lupus-prone mice.

Nature communications·2025
Same author

[Preschool-age children maintain a distinct immunological memory after SARS-CoV-2 infection].

Medecine sciences : M/S·2025
Same author

Sex-specific impact of B cell-derived IL-10 on tuberculosis resistance.

Frontiers in immunology·2025
Same journal

Fast Generation of F(Ab')<sub>2</sub> Fragments From Human IgG Using Fc-Fused IgG-Degrading Enzyme.

European journal of immunology·2026
Same journal

Generation of Regulatory T Cells Against Islet Neoantigen.

European journal of immunology·2026
Same journal

Complement Inhibition in the Clinic: Are We Doing Enough to Protect Patients From Infection?

European journal of immunology·2026
Same journal

Special Issue: yEFIS 3rd Symposium.

European journal of immunology·2026
Same journal

CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16<sup>INK4A</sup> in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.

European journal of immunology·2026
Same journal

Induction of Humoral and Cellular Immunity After SARS-CoV-2 JN.1 Vaccination in Individuals With and Without Prior Infection.

European journal of immunology·2026
See all related articles

Toll-like receptor (TLR) stimulation enhances naive human B cell activation and antibody production during T-dependent immune responses. These TLR signals can directly impact B cells or be delivered indirectly via dendritic cells, crucial for adaptive immunity.

Area of Science:

  • Immunology
  • Cell Biology
  • Innate Immunity

Background:

  • Lymphocyte priming is critical for effective adaptive immunity and self-tolerance.
  • Dendritic cell maturation, induced by innate immune receptor signals like Toll-like receptors (TLRs), is essential for naive T cell priming.
  • Understanding B cell activation mechanisms is key to developing immunotherapies.

Discussion:

  • This study demonstrates that Toll-like receptor (TLR) stimulation significantly boosts naive human B cell activation.
  • TLR signaling potentiates antibody production in T-dependent immune responses.
  • TLR-mediated signals can reach B cells either directly or indirectly through activated dendritic cells.

Key Insights:

  • TLR stimulation is a potent enhancer of naive human B cell activation and antibody secretion.

Related Experiment Videos

  • Both direct and indirect TLR signaling pathways contribute to B cell potentiation.
  • This finding highlights the role of innate immunity in shaping adaptive B cell responses.

    • Outlook:

    • Further research into TLR-mediated B cell potentiation could lead to novel vaccine adjuvants.
    • Understanding these pathways may offer new strategies for treating autoimmune diseases.
    • Investigating the precise mechanisms of indirect TLR signaling via dendritic cells warrants further study.